416 related articles for article (PubMed ID: 26681751)
41. Angiotensinogen gene knockout delays and attenuates cold-induced hypertension.
Sun Z; Cade R; Zhang Z; Alouidor J; Van H
Hypertension; 2003 Feb; 41(2):322-7. PubMed ID: 12574102
[TBL] [Abstract][Full Text] [Related]
42. The predominant role of brain angiotensinogen and angiotensin in environmentally induced hypertension.
Peng J; Kimura B; Phillips MI
Regul Pept; 2002 Dec; 110(1):25-32. PubMed ID: 12468106
[TBL] [Abstract][Full Text] [Related]
43. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
[TBL] [Abstract][Full Text] [Related]
44. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
Nuotio-Antar AM; Hachey DL; Hasty AH
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1517-28. PubMed ID: 17878220
[TBL] [Abstract][Full Text] [Related]
45. NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet.
Amato A; Caldara GF; Nuzzo D; Baldassano S; Picone P; Rizzo M; Mulè F; Di Carlo M
Nutrients; 2017 May; 9(5):. PubMed ID: 28505074
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of mouse angiotensinogen in renal proximal tubule causes salt-sensitive hypertension in mice.
Ying J; Stuart D; Hillas E; Gociman BR; Ramkumar N; Lalouel JM; Kohan DE
Am J Hypertens; 2012 Jun; 25(6):684-9. PubMed ID: 22378037
[TBL] [Abstract][Full Text] [Related]
47. Response to genetic manipulations of liver angiotensinogen in the physiological range.
Gociman B; Rohrwasser A; Hillas E; Cheng T; Hunter G; Hunter J; Lott P; Monson S; Ying J; Lalouel JM
J Hum Genet; 2008; 53(9):775-788. PubMed ID: 18600297
[TBL] [Abstract][Full Text] [Related]
48. Deletion of AT1a (Angiotensin II Type 1a) Receptor or Inhibition of Angiotensinogen Synthesis Attenuates Thoracic Aortopathies in Fibrillin1
Chen JZ; Sawada H; Ye D; Katsumata Y; Kukida M; Ohno-Urabe S; Moorleghen JJ; Franklin MK; Howatt DA; Sheppard MB; Mullick AE; Lu HS; Daugherty A
Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2538-2550. PubMed ID: 34407634
[TBL] [Abstract][Full Text] [Related]
49. Effect of the angiotensinogen genotype on experimental hypertension in mice.
Handtrack C; Cordasic N; Klanke B; Veelken R; Hilgers KF
J Mol Med (Berl); 2007 Apr; 85(4):343-50. PubMed ID: 17333097
[TBL] [Abstract][Full Text] [Related]
50. A polymorphism in intron I of the human angiotensinogen gene (
Mopidevi B; Kaw MK; Sivankutty I; Jain S; Perla SK; Kumar A
J Biol Chem; 2019 Aug; 294(31):11829-11839. PubMed ID: 31201268
[TBL] [Abstract][Full Text] [Related]
51. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity.
Hopkins PN; Lifton RP; Hollenberg NK; Jeunemaitre X; Hallouin MC; Skuppin J; Williams CS; Dluhy RG; Lalouel JM; Williams RR; Williams GH
J Hypertens; 1996 Feb; 14(2):199-207. PubMed ID: 8728297
[TBL] [Abstract][Full Text] [Related]
52. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
[TBL] [Abstract][Full Text] [Related]
53. Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr
Rajamoorthi A; Lee RG; Baldán Á
Atherosclerosis; 2018 Aug; 275():43-49. PubMed ID: 29859472
[TBL] [Abstract][Full Text] [Related]
54. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
[TBL] [Abstract][Full Text] [Related]
56. Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension.
Tang X; Mohuczy D; Zhang YC; Kimura B; Galli SM; Phillips MI
Am J Physiol; 1999 Dec; 277(6):H2392-9. PubMed ID: 10600860
[TBL] [Abstract][Full Text] [Related]
57. Pathologic HDAC1/c-Myc signaling axis is responsible for angiotensinogen transcription and hypertension induced by high-fat diet.
Youn EK; Cho HM; Jung JK; Yoon GE; Eto M; Kim JI
Biomed Pharmacother; 2023 Aug; 164():114926. PubMed ID: 37244179
[TBL] [Abstract][Full Text] [Related]
58. Absence of peroxisome proliferator-activated receptor-alpha abolishes hypertension and attenuates atherosclerosis in the Tsukuba hypertensive mouse.
Tordjman KM; Semenkovich CF; Coleman T; Yudovich R; Bak S; Osher E; Vechoropoulos M; Stern N
Hypertension; 2007 Nov; 50(5):945-51. PubMed ID: 17909121
[TBL] [Abstract][Full Text] [Related]
59. Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen.
Tomita N; Morishita R; Higaki J; Aoki M; Nakamura Y; Mikami H; Fukamizu A; Murakami K; Kaneda Y; Ogihara T
Hypertension; 1995 Jul; 26(1):131-6. PubMed ID: 7541778
[TBL] [Abstract][Full Text] [Related]
60. Deficiency of receptor-associated protein attenuates angiotensin II-induced atherosclerosis in hypercholesterolemic mice without influencing abdominal aortic aneurysms.
Wang S; Subramanian V; Lu H; Howatt DA; Moorleghen JJ; Charnigo R; Cassis LA; Daugherty A
Atherosclerosis; 2012 Feb; 220(2):375-80. PubMed ID: 22153700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
